TORONTO, June 04, 2025--(BUSINESS WIRE)--Flow Beverage Corp. (TSX:FLOW; OTCQX:FLWBF) ("Flow" or the "Company") announced today having entered into its previously announced secured business purpose ...
Direct Flow Medical Inc., a Santa Rosa-based heart valve startup that manufactures its devices in Lake Forest, has had a busy January. The company makes replacement aortic transcatheter valves used to ...
The NFS Term Note will mature on May 23, 2028 three years from the date of issue (the "NFS Note Maturity Date"), and bear interest at a rate of 15% per annum ("NFS Note Interest") accruing on the ...
A new liquid biopsy test that uses flow cytometry to detect cancer cells has been FDA approved for chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome, and ...
If you have been staring at CRISPR Therapeutics stock lately, wondering whether it is time to buy, hold, or rethink your position, you are far from alone. Over the past week, the stock has surged 16.1 ...
SANTA ROSA, Calif.--(BUSINESS WIRE)--Direct Flow Medical ®, Inc., a transcatheter heart valve company focused on improving patient outcomes, today announced that it has received approval from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback